Topics Covered:
- How Waldenström macroglobulinemia (WM) is diagnosed
- The factors taken into consideration when developing treatment plans for WM
- Current and emerging treatments for WM and side-effect management
We hope you find this video informative and helpful. We would really appreciate your feedback, which helps us to plan future resources.
Program Materials:
Speaker:
Joshua Richter, MD, FACP
Associate Professor, Medicine
Tisch Cancer Institute and Icahn School of Medicine
Director, Myeloma
Blavatnik Family Chelsea Medical Center at Mount Sinai
New York, NY